Saturday, January 31, 2026

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Palantir Hits New Record High Amid AI Surge, Surpassing Samsung’s Market Cap

Palantir's stock surged over 5%, reaching a record high of $116.65, driven by strong earnings and growing private sector demand.

Is Russia Protecting North Korea’s Illegal Acts?

The Ministry of Unification expressed deep regret...

Tag: eocnomy

NVIDIA Surges While Apple Plunges on the Stock Market

While NVIDIA's stock continues to surge, Apple's stock has fallen for six consecutive trading days, rapidly narrowing the market capitalization gap between them. As of...

Top News

- Our Sponsors Ad -

Follow us